An Open-Label Study Of Lamictal In Neurotic Excoriation

Inclusion Criteria: men and women age 18-65 current diagnosis of neurotic excoriation Exclusion Criteria: unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination history of seizures myocardial infarction within 6 months current pregnancy or lactation, or inadequate contraception in women of childbearing potential a need for medication other than Lamictal with possible psychotropic effects or unfavorable interactions with Lamictal clinically significant suicidality lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder current or recent (past 3 months) DSM-IV substance abuse or dependence illegal substance use within 2 weeks of study initiation initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline previous treatment with Lamictal treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline current treatment with an anti-epileptic medication and patients who have previously been diagnosed with a medical condition that cause skin itchiness (e.g. liver, kidney, and blood diseases, etopic allergies)